Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: Q4QEA4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 85 | 89 | PF00656 | 0.627 |
CLV_PCSK_SKI1_1 | 28 | 32 | PF00082 | 0.602 |
DEG_MDM2_SWIB_1 | 7 | 14 | PF02201 | 0.629 |
DOC_CKS1_1 | 123 | 128 | PF01111 | 0.633 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.626 |
DOC_USP7_MATH_1 | 71 | 75 | PF00917 | 0.562 |
DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.650 |
DOC_USP7_MATH_1 | 93 | 97 | PF00917 | 0.684 |
DOC_USP7_UBL2_3 | 20 | 24 | PF12436 | 0.605 |
DOC_WW_Pin1_4 | 122 | 127 | PF00397 | 0.638 |
LIG_14-3-3_CanoR_1 | 28 | 35 | PF00244 | 0.621 |
LIG_14-3-3_CanoR_1 | 56 | 64 | PF00244 | 0.606 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.611 |
LIG_BRCT_BRCA1_1 | 3 | 7 | PF00533 | 0.558 |
LIG_BRCT_BRCA1_1 | 73 | 77 | PF00533 | 0.631 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.643 |
LIG_FHA_2 | 14 | 20 | PF00498 | 0.708 |
LIG_LIR_Apic_2 | 33 | 38 | PF02991 | 0.663 |
LIG_LIR_Gen_1 | 109 | 119 | PF02991 | 0.719 |
LIG_LIR_Nem_3 | 97 | 103 | PF02991 | 0.669 |
LIG_Pex14_2 | 3 | 7 | PF04695 | 0.606 |
LIG_SH2_CRK | 100 | 104 | PF00017 | 0.612 |
LIG_SH2_CRK | 143 | 147 | PF00017 | 0.687 |
LIG_SH2_CRK | 35 | 39 | PF00017 | 0.650 |
LIG_SH2_GRB2like | 35 | 38 | PF00017 | 0.656 |
LIG_SH2_NCK_1 | 35 | 39 | PF00017 | 0.696 |
LIG_SH2_SRC | 35 | 38 | PF00017 | 0.656 |
LIG_SH2_STAP1 | 108 | 112 | PF00017 | 0.607 |
LIG_SH2_STAT3 | 130 | 133 | PF00017 | 0.720 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.723 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.701 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.519 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.611 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.733 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.536 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.632 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.693 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.553 |
MOD_GlcNHglycan | 84 | 87 | PF01048 | 0.671 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.675 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.535 |
MOD_N-GLC_1 | 82 | 87 | PF02516 | 0.643 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.610 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.602 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.582 |
MOD_NEK2_2 | 73 | 78 | PF00069 | 0.561 |
MOD_NEK2_2 | 99 | 104 | PF00069 | 0.538 |
MOD_PK_1 | 44 | 50 | PF00069 | 0.605 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.649 |
MOD_ProDKin_1 | 122 | 128 | PF00069 | 0.634 |
TRG_DiLeu_BaEn_1 | 25 | 30 | PF01217 | 0.648 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.622 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.545 |
TRG_ENDOCYTIC_2 | 143 | 146 | PF00928 | 0.687 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IAS9 | Leishmania donovani | 89% | 100% |
A4H950 | Leishmania braziliensis | 55% | 100% |
A4HXG4 | Leishmania infantum | 90% | 100% |
E9AR59 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |